BSE Live
Jan 19, 16:01Prev. Close
22.50
Open Price
22.06
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Beryl Drugs (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.05 | 0.03 | 0.05 | 0.01 | 0.01 | |
| Diluted EPS (Rs.) | 0.05 | 0.03 | 0.05 | 0.01 | 0.01 | |
| Cash EPS (Rs.) | 0.69 | 0.68 | 0.76 | 0.73 | 0.76 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 10.99 | 10.94 | 10.91 | 10.87 | 10.86 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 10.99 | 10.94 | 10.91 | 10.87 | 10.86 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 13.72 | 13.80 | 12.34 | 16.24 | 14.66 | |
| PBDIT/Share (Rs.) | 1.03 | 0.95 | 1.08 | 1.03 | 0.92 | |
| PBIT/Share (Rs.) | 0.39 | 0.30 | 0.37 | 0.39 | 0.25 | |
| PBT/Share (Rs.) | 0.18 | 0.07 | 0.12 | 0.18 | 0.04 | |
| Net Profit/Share (Rs.) | 0.05 | 0.03 | 0.05 | 0.01 | 0.01 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 7.51 | 6.84 | 8.75 | 6.34 | 6.27 | |
| PBIT Margin (%) | 2.86 | 2.17 | 2.97 | 2.39 | 1.72 | |
| PBT Margin (%) | 1.30 | 0.52 | 0.96 | 1.10 | 0.26 | |
| Net Profit Margin (%) | 0.34 | 0.21 | 0.37 | 0.04 | 0.08 | |
| Return on Networth / Equity (%) | 0.42 | 0.27 | 0.42 | 0.06 | 0.11 | |
| Return on Capital Employed (%) | 0.42 | 0.27 | 0.42 | 0.06 | 0.11 | |
| Return on Assets (%) | 0.30 | 0.20 | 0.32 | 0.04 | 0.08 | |
| Total Debt/Equity (X) | 0.14 | 0.17 | 0.15 | 0.14 | 0.17 | |
| Asset Turnover Ratio (%) | 89.31 | 92.35 | 86.35 | 108.44 | 96.55 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.00 | 2.05 | 2.23 | 2.13 | 2.12 | |
| Quick Ratio (X) | 1.44 | 1.42 | 1.39 | 1.62 | 1.65 | |
| Inventory Turnover Ratio (X) | 5.60 | 5.45 | 4.34 | 8.09 | 7.79 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
| Cash Earnings Retention Ratio (%) | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 5.43 | 5.62 | 7.55 | 1.05 | 1.03 | |
| EV/Net Operating Revenue (X) | 0.78 | 0.80 | 1.21 | 0.13 | 0.14 | |
| EV/EBITDA (X) | 10.39 | 11.74 | 13.87 | 2.03 | 2.23 | |
| MarketCap/Net Operating Revenue (X) | 0.67 | 0.69 | 1.09 | 0.07 | 0.05 | |
| Retention Ratios (%) | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
| Price/BV (X) | 0.84 | 0.87 | 1.24 | 0.10 | 0.07 | |
| Price/Net Operating Revenue | 0.67 | 0.69 | 1.09 | 0.07 | 0.05 | |
| Earnings Yield | 0.01 | 0.00 | 0.00 | 0.01 | 0.02 |
14.11.2025
Beryl Drugs Standalone September 2025 Net Sales at Rs 5.12 crore, down 8.8% Y-o-Y
22.08.2025
Beryl Drugs Standalone June 2025 Net Sales at Rs 4.79 crore, down 23.28% Y-o-Y
12.06.2025
Beryl Drugs Standalone March 2025 Net Sales at Rs 3.97 crore, up 33.54% Y-o-Y
14.02.2025
Beryl Drugs Standalone December 2024 Net Sales at Rs 5.31 crore, down 30.35% Y-o-Y
14.11.2025
Beryl Drugs Standalone September 2025 Net Sales at Rs 5.12 crore, down 8.8% Y-o-Y
22.08.2025
Beryl Drugs Standalone June 2025 Net Sales at Rs 4.79 crore, down 23.28% Y-o-Y
12.06.2025
Beryl Drugs Standalone March 2025 Net Sales at Rs 3.97 crore, up 33.54% Y-o-Y
14.02.2025
Beryl Drugs Standalone December 2024 Net Sales at Rs 5.31 crore, down 30.35% Y-o-Y